What's Going On With Canopy Growth Stock After Earnings?
What's Going On With Canopy Growth Stock After Earnings?
Canopy Growth Corporation (NASDAQ:CGC) shares are down Friday after the company reported its first-quarter financial results. Here's a look at the details from the report.
美国Canopy Growth Corporation (纳斯达克股票代码：CGC)的股价在公司发布第一季度财报后出现下跌。以下是报告的细节。
The Details:
细节：
Canopy Growth reported net revenue declined by 13% to $48.193 million in the first quarter driven mostly by the impact of divested businesses.
Canopy Growth报告，受剥离业务影响，净收入下降13％至4819.3万元。
Canada cannabis net revenue was $27.66 million, a decrease of 6% year-over-year, with record Canada medical cannabis net revenue offset by lower adult-use cannabis net revenues. Canada medical cannabis net revenue increased 20% year-over-year, driven in part by strong demand for high-margin Spectrum Therapeutics products and the broader assortment of products available through the online platform.
加拿大的大麻净收入为2766万元，同比减少6％，创下纪录的加拿大医疗大麻净收入抵消了较低的成年人用大麻净收入。加拿大的医疗大麻净收入同比增长20％，部分原因是高毛利的Spectrum Therapeutics产品的强劲需求和在线平台提供的更多产品。
International markets cannabis net revenue declined 1% from the same period last year, with growth in high-margin Poland offset by a decline in Australia.
国际市场的大麻净收入同比下降1％，在高毛利的波兰增长抵消了澳大利亚的下降。
"The fundamentals of our business continue to strengthen, and our focus on profitable revenue generation is yielding clear results as we set the stage for growth in the second half of fiscal 2025. With our core businesses delivering adjusted EBITDA profitability and primed for growth, paired with Canopy USA's positioning to benefit from near-term market opportunities in the U.S., Canopy Growth is advancing rapidly and is well established for multi-market cannabis leadership," said David Klein, CEO of Canopy Growth.
“我们业务的基本面继续强化，我们专注于盈利收入的发展正在产生明显的结果，我们正在为2025财年下半年的增长做好准备。随着我们的核心业务实现了调整后的EBITDA盈利能力并准备增长，再加上Canopy USA在美国市场机遇中的定位，Canopy Growth正在快速发展并已稳固地建立了多市场的大麻领导地位，” Canopy Growth的首席执行官David Klein说。
According to data from Benzinga Pro, Canopy Growth shares are trading below the stock's 50-day moving average of $7.11 and 14.09% of shares are being sold short.
根据Benzinga Pro的数据，Canopy Growth股票的交易价低于股票50日移动平均线7.11美元，14.09％的股份被卖空。
Will CGC Stock Go Up?
CGC股票会上涨吗？
When trying to assess whether or not Canopy Growth will trade higher from current levels, it's a good idea to take a look at analyst forecasts.
在试图评估Canopy Growth是否将从当前水平上涨时，最好看一下分析师的预测。
Wall Street analysts have an average 12-month price target of $2 on Canopy Growth. In the last month, no analysts have adjusted price targets. Here's a look at recent price target changes [Analyst Ratings]. Benzinga also tracks Wall Street's most accurate analysts. Check out how analysts covering Canopy Gwth have performed in recent history.
华尔街分析师对Canopy Growth的平均12个月价格目标为2美元。在过去一个月中，没有分析师调整过价格目标。以下是最近的价格目标变化[分析师评级]。Benzinga还追踪华尔街最准确的分析师。查看涵盖Canopy Gwth的分析师表现的最新历史记录。
Stocks don't move in a straight line. The average stock market return is approximately 10% per year. Canopy Growth is 44.47% up year-to-date. The average analyst price target suggests the stock could have further downside ahead.
股票价格不会一直向上。股市的平均回报率约为10％。Canopy Growth今年迄今为止上涨44.47％。平均分析师价格目标表明，该股票可能还存在进一步下跌的空间。
For a broad overview of everything you need to know about Canopy Gwth, visit here. If you want to go above and beyond, there's no better tool to help you do just that than Benzinga Pro. Start your free trial today.
关于Canopy Gwth的所有重要信息的全面概述，请访问此处。如果您希望更上一层楼，则没有比Benzinga Pro更好的工具来帮助您实现这一目标了。立即开始免费试用吧。
CGC Price Action: According to Benzinga Pro, Canopy Growth shares are down 7.08% at $6.43 at the time of publication Friday.
CGC股票价格行情：根据Benzinga Pro的数据，Canopy Growth股票在本周五发布时下跌了7.08％至6.43美元。
Read Also:
阅读更多：
- The Trade Desk Stock Climbs After Better-Than-Expected Q2 Results
- The Trade Desk发布超预期Q2业绩后股价上涨
Image: Pixabay
图片：Pixabay